Dhaifina Qashrina Najmy1, Siti Nur Aisyah Mohamad Asri2, Mohamed Saufi Awang2,3, Mohd Ghaddafi Wahab2,3, Khairani Idah Mokhtar4, Mohamad Shafiq Mohd Ibrahim5, Mohd Arifin Kaderi1*
1. Department of Biomedical Science, Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
2. Neuroscience Clinic, Sultan Ahmad Shah Medical Centre @IIUM, Jalan Sultan Haji Ahmad Shah, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
3. Neurosurgery Division, Department of Surgery, Kuliyyah of Medicine, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
4. Department of Fundamental Dental and Medical Sciences, Kulliyyah of Dentistry, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
5. Paediatric Dentistry & Dental Public Health, Kulliyyah of Dentistry, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia
*Corresponding author: Mohd Arifin Kaderi.
ABSTRACT
INTRODUCTION: Brain tumours are known to be relatively rare in Malaysia, yet their biological heterogeneity and poor prognosis challenge clinicians. National epidemiological data describing population-level patterns and outcomes of brain tumours remain scarce.
OBJECTIVE(S): This study characterises demographic distribution, tumour profile, and survival determinants among brain tumour patients treated at Sultan Ahmad Shah Medical Centre (SASMEC), International Islamic University Malaysia (IIUM), between 2020 and 2025.
MATERIALS & METHODS: A retrospective cohort study retrieved electronic records for all consecutive patients (n = 222). Variables extracted were age, gender, ethnicity, tumour origin (primary vs secondary), treatment modality, diagnostic methods, and survival status. Descriptive statistics were followed by chi-square tests, independent-sample t-test, binary logistic regression, and Kaplan-Meier survival analysis.
RESULTS: Primary tumours comprised 79.3% of cases. The median age was 58 years (interquartile range 43-68), with a male-to-female sex ratio of 1:1.2. Tumour origin was the sole independent predictor of survival: primary tumours were associated with a 6.6-fold higher survival likelihood and a 95.45% survival rate, compared to 76.09% for metastatic lesions (p < 0.001). Age, gender, and treatment modality showed no significant associations with survival.
CONCLUSION: This first demographic brain tumour evaluation in Pahang establishes foundational epidemiological data and confirms tumour origin as a key prognostic marker. The dataset provides a baseline for future multicentre studies integrating molecular data, advancing precision neuro-oncology and guiding resource allocation.
KEYWORDS: Brain Tumour, Epidemiology, Survival Analysis, Malaysia, Retrospective Cohort


